HD:
As you state in your post #210745, dated 08-23-2019.... the FDA should have contacted AMARIN on scope of ADCOM ... You asserted around 08-28-2019... I contacted IR on 09-02-2019....would not answer receiving communications with FDA...or draft question, since they are in ongoing talks....
You stated approx. 10-14/24-2019 the FDA to send Amarin briefing docs and DRAFT QUESTION for review ... with ongoing communications between the two, but final agreed to DOCS about 11-01-2019 to be prepared for public release....
On 11-12-2019 FDA /Amarin will post available briefing materials..
We are close in dates, but getting a copy of briefing materials and draft question would let us know if FDA is going to pull the same shenanigans as in previous ADCOM... we need to pepper AMARIN and anyone else to obtain some information, before we see some big PUT OPTION...
HD, please let us know how to avoid what took place 6 yrs ago ????
News 
Market Data 
Discover 
